The updated guidance replaces the NLA’s 2011 recommendations and reflects more than a decade of advances in genetics, imaging, and lipid-lowering therapies. “Familial hypercholesterolemia is one of the most common and dangerous genetic conditions we see, yet it remains profoundly underdiagnosed and undertreated,” said Zahid Ahmad, MD, FNLA, lead author of the document. The full consensus document, “Update on Familial Hypercholesterolemia: An Expert Clinical Consensus from the National Lipid Association,” is available open access in the Journal of Clinical Lipidology here . AuthorsZahid Ahmad, MD, FNLA; Anandita Agarwala, MD; Marina Cuchel, MD, PhD; P. Barton Duell, MD, MNLA; Robert A. Hegele, MD; Lisa Hudgins, MD; Allison Jamison, MBA; Dinesh Kalra, MD, FNLA; Amit Khera, MD; Joshua W. Knowles, MD, PhD, FNLA; Iftikhar Kullo, MD; Ana Morales, MS, CGC, Mark A. Rothstein, JD; Joseph J. Saseen, PharmD, MNLA; Daniel Soffer, MD, MNLA; Bruce A. Warden, PharmD, FNLA; William S. Weintraub, MD; Lauren Williams, RDN; Anne C. Goldberg, MD, MNLA